More importantly, using two CRPC patient-derived xenograft (PDX) models11—LuCaP 35CR and 86.2CR—we further confirmed the interactions between AR and BMI1 in prostate cancer patient tissues (Fig. 1g). This evidence concerns the gene BMI1 and prostate cancer.